Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Akihiro Hino"'
Autor:
Shinobu Oshikiri, Tomoya Uehara, Hiroyuki Suzuki, Miho Koike-Satake, Akihiro Hino, Yasushi Arano
Publikováno v:
Molecules, Vol 25, Iss 2, p 254 (2020)
The diaminedithiol (N2S2) tetradentate ligand constitutes a useful chelating molecule for preparing 99mTc-labeled compounds of high in vivo stability in high radiochemical yields. However, since the thiol groups in the N2S2 ligand are easy to be oxid
Externí odkaz:
https://doaj.org/article/997f39faddab4e31b8b8442e1097b13f
Autor:
Wakako Murakami, Shigeki Kobayashi, Takehisa Susa, Takuma Nanno, Hironori Ishiguchi, Takeki Myoren, Shigehiko Nishimura, Takayoshi Kato, Akihiro Hino, Tetsuro Oda, Shinichi Okuda, Takeshi Yamamoto, Masafumi Yano
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163250 (2016)
Catecholamines induce intracellular reactive oxygen species (ROS), thus enhancing diastolic Ca2+ leakage through the ryanodine receptor during heart failure (HF). However, little is known regarding the effect of atrial natriuretic peptide (ANP) on RO
Externí odkaz:
https://doaj.org/article/69bf3bd17be54e5688705515d1209df1
Autor:
Kentaro Fujiwara, Keitaro Koyama, Kosuke Suga, Masako Ikemura, Yasutaka Saito, Akihiro Hino, Hiroko Iwanari, Osamu Kusano-Arai, Kenichi Mitsui, Hiroyuki Kasahara, Masashi Fukayama, Tatsuhiko Kodama, Takao Hamakubo, Toshimitsu Momose
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0125468 (2015)
ROBO1 is a membrane protein that contributes to tumor metastasis and angiogenesis. We previously reported that 90Y-labeled anti-ROBO1 monoclonal antibody (90Y-anti-ROBO1 IgG) showed an antitumor effect against ROBO1-positive tumors. In this study, we
Externí odkaz:
https://doaj.org/article/3809186e4cb74335a57fd7dd6f1ab7a5
Autor:
Shigeki Kobayashi, Takehisa Susa, Hironori Ishiguchi, Takeki Myoren, Wakako Murakami, Takayoshi Kato, Masakazu Fukuda, Akihiro Hino, Takeshi Suetomi, Makoto Ono, Hitoshi Uchinoumi, Hiroki Tateishi, Mamoru Mochizuki, Tetsuro Oda, Shinichi Okuda, Masahiro Doi, Takeshi Yamamoto, Masafumi Yano
Publikováno v:
PLoS ONE, Vol 10, Iss 1, p e0114314 (2015)
OBJECTIVES:The purpose of this study was to investigate whether adding a low-dose β1-blocker to milrinone improves cardiac function in failing cardiomyocytes and the underlying cardioprotective mechanism. BACKGROUND:The molecular mechanism underlyin
Externí odkaz:
https://doaj.org/article/7463108c0a64495ba443e7e7aac03f7f
Publikováno v:
IEEJ Journal of Industry Applications. 12:264-272
Autor:
Shozo Kanezaki, Masashi Miyazaki, Tomonori Sakamoto, Akihiro Hino, Tetsutaro Abe, Noriaki Sako, Hiroshi Tsumura
Publikováno v:
Medicine; 10/20/2023, Vol. 102 Issue 42, p1-7, 7p
Autor:
Masahiko Tokura, Akihiro Hino, Yuichi Funase, Masamichi Kajita, Michi Kitano, Shinobu Oshikiri, Yasutaka Saito, Tomoya Uehara, Eri Nakamura
Publikováno v:
Journal of Nuclear Medicine
Visual Abstract
P-cadherin is overexpressed in various cancers and can be a target for radioimmunotherapy. We investigated the preclinical pharmacokinetics and pharmacology of FF-21101, an 111In- or 90Y-conjugated monoclonal antibody against P-c
P-cadherin is overexpressed in various cancers and can be a target for radioimmunotherapy. We investigated the preclinical pharmacokinetics and pharmacology of FF-21101, an 111In- or 90Y-conjugated monoclonal antibody against P-c
Publikováno v:
Journal of Musculoskeletal Research.
Purpose: This study aimed to compare the utility score of dysplastic osteoarthritis of the hip (OA) after different surgical treatments.
Methods:In this cross-sectional study, we evaluated the utility scores of 204 patients using the Short Form-
Methods:In this cross-sectional study, we evaluated the utility scores of 204 patients using the Short Form-
Autor:
Kazuomi Kario, Satoshi Hoshide, Keisuke Narita, Yukie Okawara, Hiroshi Kanegae, Kenji Aoki, Hajime Kihara, Toshiro Koga, Tomoaki Nakata, Kenji Oku, Yasufumi Matsuoka, Hiroaki Omori, Masafumi Nishizawa, Yasuo Tanno, Yoko Fukase, Koki Omi, Jun Takahashi, Hiroyuki Mizuno, Michiya Saito, Junichi Yatabe, Kazuo Eguchi, Kiyoshi Iwashita, Maki Kumada, Gaku Oki, Tomoyuki Kabutoya, Yukihiro Hojo, Masaru Ichida, Shizukiyo Ishikawa, Takahiro Komori, Yoshio Matsui, Masatoshi Matsumoto, Shoichiro Nagasaka, Masahiro Nakano, Yoshioki Nishimura, Kenta Okada, Kazuyuki Shimada, Masahisa Shimpo, Nozomu Takahashi, Hideyuki Uno, Joji Ishikawa, Toshio Kuroda, Nobutsune Hirahara, Yuta Kemi, Hisashi Yoshioka, Sakuo Hoshi, Atsuhi Mizuno, Kunihiko Ohno, Osamu Okazaki, Tsunehiro Saito, Tetsu Tanaka, Kazuo Yamashiro, Tatsuyuki Yamauchi, Shisei Yo, Shigeru Yomogita, Sayaka Hikita, Yasuhiro Kawase, Yoshifumi Nojiri, Yukihiro Sato, Kiyoshi Uchiba, Motoyuki Ishiguro, Atsushi Taguchi, Kazumasa Iida, Tatsuya Takemoto, Katsuyuki Tone, Hideyasu Abe, Yasuhisa Abe, Masami Hasegawa, Tomohiro Katsuya, Yoshiharu Okada, Shinichiro Tanaka, Genyo Tanke, Takeshi Takami, Jun Michiura, Masahiko Shiotani, Tomohiro Aoki, Koichi Ogura, Yuzuru Kawamura, Shigekiyo Nakanishi, Nobuo Sasaki, Toshiyuki Takahashi, Akihisa Fujii, Eiichiro Tanaka, Hiroyuki Katayama, Motoki Fukutomi, Kosuke Miyoshi, Hiroaki Naito, Sawa Yokota, Kazumasa Nakamura, Tetsu Yokota, Shinsuke Takasugi, Shuichiro Fujita, Yumiko Fujita, Hitoshi Kaneko, Takeshi Fujiwara, Wataru Kitamura, Yuhei Anan, Tomohiro Deguchi, Yuki Imaizumi, Jun Miyagi, Takahiro Tsuji, Yasuhiro Uchiwa, Shin Ueda, Takeya Yamaguchi, Tetsuro Yoshida, Ryo Yoshinaga, Kosuke Maeda, Kotaro Kunitomo, Kyousei Soda, Hirotoshi Baba, Keisuke Yonezu, Akihiro Hino, Genta Miura, Tomoko Nakamura, Munetoshi Kuroki, Fumihiko Omori, Toshiaki Hidaka, Takanori Hidaka, Yuichiro Yano, Yoshimasa Kanemaru, Michitaka Kitani, Masahiro Koga, Hirohide Kubo, Masachika Kuwabara, Junichi Miyata, Masahiko Nagata, Koji Sasaki, Noboru Tamaki, Hiroyasu Tasaka, Naoto Yokota, Takahiro Miyata, Eiyu Katsuren, Norifumi Kudeken, Noriharu Yagi
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 78(6)
Resistant hypertension is an important cardiovascular risk factor. This analysis of the JAMP study (Japan Ambulatory Blood Pressure Monitoring Prospective) data investigated the effects of uncontrolled resistant hypertension diagnosed using ambulator
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports
Scientific Reports
C-X-C chemokine receptor type 4 (CXCR4) constitutes a promising target for tumor diagnosis and therapy. Herein, we evaluate a new 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated CXCR4 antagonist derived from LY2510924, FRM0